| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |